Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

Evald Høj Christiansen, Lisette Okkels Jensen, Per Thayssen, Hans-Henrik Tilsted, Lars Romer Krusell, Knud Nørregaard Hansen, Anne Kjer Kaltoft, Michael Maeng, Steen Dalby Kristensen, Hans Erik Bøtker, Christian Juhl Terkelsen, Anton Boel Villadsen, Jan Ravkilde, Jens Aarøe, Morten Madsen, Leif Thuesen, Jens Flensted Lassen, Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) V investigators

Research output: Contribution to journalJournal articleResearchpeer-review

172 Citations (Scopus)
919 Downloads (Pure)

Abstract

Third-generation biodegradable polymer drug-eluting stents might reduce the risk of stent thrombosis compared with first-generation permanent polymer drug-eluting stents. We aimed to further investigate the effects of a biodegradable polymer biolimus-eluting stent compared with a durable polymer-coated sirolimus-eluting stent in a population-based setting.
Original languageEnglish
JournalLancet
Volume381
Issue number9867
Pages (from-to)661-669
Number of pages9
ISSN0140-6736
DOIs
Publication statusPublished - 23 Feb 2013

Keywords

  • Absorbable Implants
  • Acute Coronary Syndrome
  • Aged
  • Aspirin
  • Coated Materials, Biocompatible
  • Coronary Artery Disease
  • Coronary Thrombosis
  • Drug-Eluting Stents
  • Female
  • Humans
  • Male
  • Myocardial Infarction
  • Percutaneous Coronary Intervention
  • Platelet Aggregation Inhibitors
  • Polymers
  • Retreatment
  • Sirolimus

Fingerprint

Dive into the research topics of 'Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial'. Together they form a unique fingerprint.

Cite this